BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $253,000 | -67.8% | 148,272 | -36.3% | 0.00% | -100.0% |
Q1 2019 | $786,000 | +15.6% | 232,945 | +0.2% | 0.00% | 0.0% |
Q4 2018 | $680,000 | -48.9% | 232,546 | +7.6% | 0.00% | 0.0% |
Q3 2018 | $1,331,000 | -22.5% | 216,039 | -7.2% | 0.00% | 0.0% |
Q2 2018 | $1,718,000 | +103.6% | 232,703 | +81.1% | 0.00% | 0.0% |
Q1 2018 | $844,000 | -5.6% | 128,524 | +21.0% | 0.00% | 0.0% |
Q4 2017 | $894,000 | -41.0% | 106,189 | -19.1% | 0.00% | 0.0% |
Q3 2017 | $1,516,000 | +45.3% | 131,217 | +47.1% | 0.00% | 0.0% |
Q2 2017 | $1,043,000 | +14.6% | 89,222 | +21.1% | 0.00% | 0.0% |
Q1 2017 | $910,000 | -4.0% | 73,666 | +5.9% | 0.00% | 0.0% |
Q4 2016 | $948,000 | -27.7% | 69,562 | +5.6% | 0.00% | -50.0% |
Q3 2016 | $1,311,000 | +134.5% | 65,866 | +52.8% | 0.00% | +100.0% |
Q2 2016 | $559,000 | +147.3% | 43,097 | +78.4% | 0.00% | – |
Q1 2016 | $226,000 | -53.1% | 24,161 | +1.7% | 0.00% | -100.0% |
Q4 2015 | $482,000 | +42.6% | 23,753 | +2.2% | 0.00% | – |
Q3 2015 | $338,000 | -27.5% | 23,233 | +6.1% | 0.00% | -100.0% |
Q2 2015 | $466,000 | – | 21,902 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |